{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:06:12Z","timestamp":1766826372153,"version":"3.48.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["H122C1936"],"award-info":[{"award-number":["H122C1936"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009859","name":"Geoffrey Beene Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009859","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Laurance S. Rockefeller Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-025-01712-z","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T04:51:22Z","timestamp":1762491082000},"page":"1475-1491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complementary Chinese Herbal Medicine Use and Gastrointestinal Cancers: A Scoping Review of Usage Patterns and Survival Outcomes in Taiwanese Population-Based Studies"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6478-6706","authenticated-orcid":false,"given":"Chun Sing","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunbin","family":"Kwag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Chimonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel L.","family":"Cytryn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Nien","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Rong","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth D.","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun J.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"1","key":"1712_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335-e4915.","journal-title":"Gastroenterology"},{"issue":"3","key":"1712_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1712_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649\u2013e582.","journal-title":"Gastroenterology"},{"key":"1712_CR4","doi-asserted-by":"publisher","first-page":"101404","DOI":"10.1016\/j.eclinm.2022.101404","volume":"47","author":"E Morgan","year":"2022","unstructured":"Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study. EClinicalMed. 2022;47:101404.","journal-title":"EClinicalMed"},{"issue":"10","key":"1712_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174.","journal-title":"Transl Oncol"},{"issue":"3","key":"1712_CR6","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264\u201379.","journal-title":"CA Cancer J Clin"},{"key":"1712_CR7","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, et al. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065.","journal-title":"Nat Rev Dis Primers"},{"key":"1712_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320970354","volume":"11","author":"M O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly M, Mellotte G, Ryan B, O\u2019Connor A. Gastrointestinal side effects of cancer treatments. Ther Adv Chronic Dis. 2020;11:2040622320970354.","journal-title":"Ther Adv Chronic Dis"},{"issue":"4","key":"1712_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3747\/co.v17i4.522","volume":"17","author":"Z Kassam","year":"2010","unstructured":"Kassam Z, Mackay H, Buckley CA, Fung S, Pintile M, Kim J, et al. Evaluating the impact on quality of life of chemoradiation in gastric cancer. Curr Oncol. 2010;17(4):77\u201384.","journal-title":"Curr Oncol"},{"issue":"03","key":"1712_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1142\/S0192415X24500253","volume":"52","author":"Y Liu","year":"2024","unstructured":"Liu Y, Fang C, Luo J, Gong C, Wang L, Zhu S. Traditional Chinese medicine for cancer treatment. Am J Chin Med. 2024;52(03):583\u2013604.","journal-title":"Am J Chin Med"},{"issue":"4","key":"1712_CR11","first-page":"1482","volume":"24","author":"G Calibasi-Kocal","year":"2019","unstructured":"Calibasi-Kocal G, Pakdemirli A, Bayrak S, Ozupek NM, Sever T, Basbinar Y, et al. Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer. J Buon. 2019;24(4):1482\u20137.","journal-title":"J Buon"},{"key":"1712_CR12","doi-asserted-by":"publisher","first-page":"153473542312262","DOI":"10.1177\/15347354231226256","volume":"23","author":"S-D Kim","year":"2024","unstructured":"Kim S-D, Kim J-H, Kim D-H, Park J-H, Gong Y, Sun C, et al. Comprehensive evaluation of traditional herbal medicine combined with adjuvant chemotherapy on Post-Surgical gastric cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2024;23:15347354231226256.","journal-title":"Integr Cancer Ther"},{"key":"1712_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10120-012-0164-3","volume":"16","author":"S Takiguchi","year":"2013","unstructured":"Takiguchi S, Hiura Y, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, et al. Effect of rikkunshito, a Japanese herbal medicine, on gastrointestinal symptoms and Ghrelin levels in gastric cancer patients after gastrectomy. Gastric Cancer. 2013;16:167\u201374.","journal-title":"Gastric Cancer"},{"key":"1712_CR14","doi-asserted-by":"publisher","first-page":"625493","DOI":"10.1155\/2014\/625493","volume":"2014","author":"L Zhao","year":"2014","unstructured":"Zhao L, Zhao AG, Zhao G, Xu Y, Zhu XH, Cao ND, et al. Survival benefit of traditional Chinese herbal medicine (a herbal formula for invigorating spleen) in gastric cancer patients with peritoneal metastasis. Evid Based Complement Alternat Med. 2014;2014:625493.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1712_CR15","doi-asserted-by":"publisher","first-page":"640576","DOI":"10.3389\/fphar.2021.640576","volume":"12","author":"K Inokuchi","year":"2021","unstructured":"Inokuchi K, Masaoka T, Kanai T. Rikkunshito as a therapeautic agent for functional dyspepsia and its prokinetic and non-prokinetic effects. Front Pharmacol. 2021;12:640576.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1712_CR16","first-page":"566","volume":"11","author":"A Fani Pakdel","year":"2021","unstructured":"Fani Pakdel A, Hatami A, Salek R, Taghizadeh-Kermani A, Javadinia SA, Ghorbani A. Effects of a polyherbal formulation on the quality of life and survival of patients with common upper gastrointestinal cancers: A randomized placebo-controlled trial. Avicenna J Phytomed. 2021;11(6):566\u201375.","journal-title":"Avicenna J Phytomed"},{"issue":"6","key":"1712_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jpainsymman.2015.12.330","volume":"51","author":"X Ye","year":"2016","unstructured":"Ye X, Lu D, Chen X, Li S, Chen Y, Deng LA. Multicenter, randomized, double-blind, placebo-controlled trial of shuangbai san for treating primary liver cancer patients with cancer pain. J Pain Symptom Manage. 2016;51(6):979\u201386.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"1712_CR18","first-page":"446","volume":"42","author":"WU Tong","year":"2022","unstructured":"Tong WU, Zhiyun Y, Yuying Y, Yuyong J, Peipei M, Huimin L, et al. Effect of decoction of Fuzheng Jiedu Xiaoji formula plus chemoembolization on primary liver cancer in patients. J Tradit Chin Med. 2022;42(3):446\u201350.","journal-title":"J Tradit Chin Med"},{"key":"1712_CR19","doi-asserted-by":"publisher","first-page":"153606","DOI":"10.1016\/j.phymed.2021.153606","volume":"88","author":"S Shao","year":"2021","unstructured":"Shao S, Jia R, Zhao L, Zhang Y, Guan Y, Wen H, et al. Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4\/MyD88\/NF-\u03baB signaling pathway. Phytomedicine. 2021;88:153606.","journal-title":"Phytomedicine"},{"issue":"7","key":"1712_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"doi-asserted-by":"crossref","unstructured":"Hsieh C-Y, Su C-C, Shao S-C, Sung S-F, Lin S-J, Kao Yang Y-H, Lai EC-C. Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol. 2019:349\u2009\u2013\u200958.","key":"1712_CR21","DOI":"10.2147\/CLEP.S196293"},{"unstructured":"Taiwan National Health Insurance Administration. List of Traditional Chinese Medicine Drugs. 2024. Available from: https:\/\/www.nhi.gov.tw\/ch\/cp-14300-03585-2467-1.html. Last accessed Aug 12, 2025.","key":"1712_CR22"},{"issue":"6","key":"1712_CR23","doi-asserted-by":"publisher","first-page":"e18457","DOI":"10.2196\/18457","volume":"22","author":"S-F Sung","year":"2020","unstructured":"Sung S-F, Hsieh C-Y, Hu Y-H. Two decades of research using Taiwan\u2019s national health insurance claims data: bibliometric and text mining analysis on pubmed. J Med Internet Res. 2020;22(6):e18457.","journal-title":"J Med Internet Res"},{"unstructured":"Taiwan Ministry of Health and Welfare. Quality Control of TCM. Available from: https:\/\/www.mohw.gov.tw\/cp-3701-58121-2.html. Last accessed Aug 12, 2025.","key":"1712_CR24"},{"unstructured":"Taiwan Ministry of Health and Welfare. Taiwan Herbal Pharmacopeia. Available from: https:\/\/www.mohw.gov.tw\/lp-3690-2.html. Last accessed Aug 12, 2025.","key":"1712_CR25"},{"unstructured":"Taiwan National Health Insurance Administration. NHI-contracted healthcare providers and benefits. https:\/\/www.nhi.gov.tw\/en\/cp-1065-d7cde-125-2.html. Last Accessed Aug 12, 2025.","key":"1712_CR26"},{"issue":"1","key":"1712_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335\u201349. e15.","journal-title":"Gastroenterology"},{"issue":"1","key":"1712_CR28","first-page":"19","volume":"8","author":"MA Pourhoseingholi","year":"2015","unstructured":"Pourhoseingholi MA, Vahedi M, Baghestani AR. urden of gastrointestinal cancer in Asia; an overview. Gastroenterol Hepatol Bed Bench. 2015;8(1):19.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"unstructured":"Covidence systematic review software. Veritas health innovation, Melbourne, Australia. Available at www.covidence.org","key":"1712_CR29"},{"issue":"12","key":"1712_CR30","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1111\/liv.12847","volume":"35","author":"YH Liao","year":"2015","unstructured":"Liao YH, Lin CC, Lai HC, Chiang JH, Lin JG, Li TC. Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients. Liver Int. 2015;35(12):2595\u2013602.","journal-title":"Liver Int"},{"key":"1712_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.102213","volume":"47","author":"F-J Tsai","year":"2019","unstructured":"Tsai F-J, Liu X, Chen C-J, Li T-M, Chiou J-S, Chuang P-H, et al. Chinese herbal medicine therapy and the risk of overall mortality for patients with liver cancer who underwent surgical resection in Taiwan. Complement Ther Med. 2019;47:102213.","journal-title":"Complement Ther Med"},{"key":"1712_CR32","doi-asserted-by":"publisher","first-page":"153473542091527","DOI":"10.1177\/1534735420915275","volume":"19","author":"Y-P Liao","year":"2020","unstructured":"Liao Y-P, Kung P-T, Wang Y-H, Chu Y-R, Kao S-T, Tsai W-C. Effects and relative factors of adjunctive Chinese medicine therapy on survival of hepatocellular carcinoma patients: a retrospective cohort study in Taiwan. Integr Cancer Ther. 2020;19:1534735420915275.","journal-title":"Integr Cancer Ther"},{"key":"1712_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jep.2017.02.004","volume":"199","author":"K-F Hung","year":"2017","unstructured":"Hung K-F, Hsu C-P, Chiang J-H, Lin H-J, Kuo Y-T, Sun M-F, et al. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: a nationwide retrospective matched-cohort study. J Ethnopharmacol. 2017;199:168\u201374.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1712_CR34","first-page":"7584631","volume":"2021","author":"W-T Shih","year":"2021","unstructured":"Shih W-T, Yang P-R, Shen Y-C, Yang Y-H, Wu C-Y. Traditional Chinese medicine enhances survival in patients with gastric cancer after surgery and adjuvant chemotherapy in taiwan: a nationwide matched cohort study. Evidence-Based Complement Altern Med. 2021;2021(1):7584631.","journal-title":"Evidence-Based Complement Altern Med"},{"issue":"2","key":"1712_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/1534735417722224","volume":"17","author":"Y-T Kuo","year":"2018","unstructured":"Kuo Y-T, Liao H-H, Chiang J-H, Wu M-Y, Chen B-C, Chang C-M, et al. Complementary Chinese herbal medicine therapy improves survival of patients with pancreatic cancer in taiwan: a nationwide population-based cohort study. Integr Cancer Ther. 2018;17(2):411\u201322.","journal-title":"Integr Cancer Ther"},{"key":"1712_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jep.2017.08.011","volume":"209","author":"Y-Y Lin","year":"2017","unstructured":"Lin Y-Y, Lee I-Y, Huang W-S, Lin Y-S, Kuan F-C, Shu L-H, et al. Danshen improves survival of patients with colon cancer and Dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway. J Ethnopharmacol. 2017;209:305\u201316.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1712_CR37","first-page":"8497084","volume":"2022","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zhao Y, Liu H, Jing C. Efficacy of traditional Chinese medicine combined with chemotherapy in the treatment of gastric cancer: a meta-analysis. Comput Math Methods Med. 2022;2022(1):8497084.","journal-title":"Comput Math Methods Med"},{"issue":"4","key":"1712_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ctim.2012.02.004","volume":"20","author":"LL Zhong","year":"2012","unstructured":"Zhong LL, Chen H-Y, Cho WC, Meng X-m, Tong Y. The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis. Complement Ther Med. 2012;20(4):240\u201352.","journal-title":"Complement Ther Med"},{"issue":"1","key":"1712_CR39","first-page":"350730","volume":"2015","author":"B Li","year":"2015","unstructured":"Li B, Gan R, Yang Q, Huang J, Chen P, Wan L, Guo C. Chinese herbal medicines as an adjunctive therapy for unresectable pancreatic cancer: a systematic review and meta-analysis. Evidence\u2010Based Complement Altern Med. 2015;2015(1):350730.","journal-title":"Evidence\u2010Based Complement Altern Med"},{"key":"1712_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11684-017-0512-0","volume":"11","author":"L Ma","year":"2017","unstructured":"Ma L, Wang B, Long Y, Li H. Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis. Front Med. 2017;11:191\u2013202.","journal-title":"Front Med"},{"issue":"52","key":"1712_CR41","doi-asserted-by":"publisher","first-page":"lgx015","DOI":"10.1093\/jncimonographs\/lgx015","volume":"2017","author":"Y Xu","year":"2017","unstructured":"Xu Y, Mao JJ, Sun L, Yang L, Li J, Hao Y, et al. Association between use of traditional Chinese medicine herbal therapy and survival outcomes in patients with stage II and III colorectal cancer: a multicenter prospective cohort study. J Natl Cancer Inst Monogr. 2017;2017(52):lgx015.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1712_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12358","author":"S Cheng","year":"2022","unstructured":"Cheng S, Zhao H, Meng Y, Guo Y, Yao M, Xu X, et al. Impact of treatment-duration-ratio of traditional Chinese medicine on survival period of primary liver cancer\u2014a real-world study. Heliyon. 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12358.","journal-title":"Heliyon"},{"key":"1712_CR43","doi-asserted-by":"publisher","first-page":"117994","DOI":"10.1016\/j.jep.2024.117994","volume":"327","author":"B-J Liu","year":"2024","unstructured":"Liu B-J, Guan Y-Y, Qiao L-X, Zhang J-M, Li A-J, Yang P-X, et al. The mechanism and experimental verification of ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: ixeris sonchifolia induces hepatocellular carcinoma apoptosis via the PI3K\/AKT pathway. J Ethnopharmacol. 2024;327:117994.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"1712_CR44","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.4251\/wjgo.v16.i9.3798","volume":"16","author":"M Micucci","year":"2024","unstructured":"Micucci M, Xiang B-Z, Ting C-M, Kwan H-Y, Mari M, Retini M, et al. Matching traditional Chinese medicine and Western medicine-based research: advanced nutraceutical development for proactive gastric cancer prevention. World J Gastrointest Oncol. 2024;16(9):3798.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"1712_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13020-023-00774-0","volume":"18","author":"R Wu","year":"2023","unstructured":"Wu R, Xi Z, Liu M, Ren H, Dai R, Jiang X, et al. Pulsatilla decoction and its bioactive component \u03b2-peltatin induce G2\/M cell cycle arrest and apoptosis in pancreatic cancer. Chin Med. 2023;18(1):61.","journal-title":"Chin Med"},{"issue":"1","key":"1712_CR46","first-page":"2310639","volume":"2019","author":"T Wang","year":"2019","unstructured":"Wang T, Fu X, Wang Z. Danshen formulae for cancer: a systematic review and meta-analysis of high\u2010quality randomized controlled trials. Evidence\u2010Based Complement Altern Med. 2019;2019(1):2310639.","journal-title":"Evidence\u2010Based Complement Altern Med"},{"key":"1712_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110735","volume":"130","author":"X Han","year":"2020","unstructured":"Han X, Zhang X, Wang Q, Wang L, Yu S. Antitumor potential of Hedyotis diffusa Willd: a systematic review of bioactive constituents and underlying molecular mechanisms. Biomed Pharmacother. 2020;130:110735.","journal-title":"Biomed Pharmacother"},{"issue":"26","key":"1712_CR48","first-page":"4259","volume":"6","author":"T Wang","year":"2012","unstructured":"Wang T, Wang S, Xiao D. A review of phytochemistry and antitumor activity of a valuable medicinal species: scutellaria barbata. J Med Plants Res. 2012;6(26):4259\u201375.","journal-title":"J Med Plants Res"},{"issue":"10","key":"1712_CR49","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.phymed.2013.03.025","volume":"20","author":"H Xu","year":"2013","unstructured":"Xu H, Yu J, Sun Y, Xu X, Li L, Xue M, Du G. Scutellaria Barbata D. Don extract synergizes the antitumor effects of low dose 5-fluorouracil through induction of apoptosis and metabolism. Phytomedicine. 2013;20(10):897\u2013903.","journal-title":"Phytomedicine"},{"issue":"3","key":"1712_CR50","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s10943-016-0299-3","volume":"56","author":"Y Mou","year":"2017","unstructured":"Mou Y. Predicting the use of traditional Chinese medicine health maintenance approach from cultural and spiritual perspectives. J Relig Health. 2017;56(3):971\u201385.","journal-title":"J Relig Health"},{"issue":"7","key":"1712_CR51","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41416-020-0741-x","volume":"122","author":"YB Zhang","year":"2020","unstructured":"Zhang YB, Pan XF, Chen J, Cao A, Zhang YG, Xia L, et al. Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies. Br J Cancer. 2020;122(7):1085\u201393.","journal-title":"Br J Cancer"},{"key":"1712_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcrc.2016.07.017","volume":"36","author":"M Jones","year":"2016","unstructured":"Jones M, Fowler R. Immortal time bias in observational studies of time-to-event outcomes. J Crit Care. 2016;36:195\u20139.","journal-title":"J Crit Care"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01712-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01712-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01712-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:02:21Z","timestamp":1766826141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01712-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1712"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01712-z","relation":{},"ISSN":["1534-6269"],"issn-type":[{"type":"electronic","value":"1534-6269"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. (This study does not involve human or animals as subjects.)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Eileen M. O\u2019Reilly reports the following disclosures: (1) Research Funding to MSK: Genentech\/Roche, BioNTech, AstraZeneca, Arcus, Elicio, Parker Institute, Digestive Care, Break Through Cancer, Agenus, Amgen, Revolution Medicines; (2) Consulting\/DSMB: Arcus, AstraZeneca, Ability Pharma, Alligator BioSciences, Agenus, BioNTech, Ipsen, Ikena, Merck, Moma Therapeutics, Novartis, Astellas, BMS, Revolution Medicines, Regeneron, Tango; Compensated: Leap Therapeutics; (3) Travel: BioNTech, Arcus, Abbvie, AstraZeneca (spouse); (4) Other: American Association of Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Imedex, Research To Practice, Stand Up To Cancer (SU2C).\u00a0Jun J. Mao reports the following disclosures: 1) Research Funding to\u00a0MSK: Tibet Cheezheng Tibetan Medicine Co. Ltd., Zhongke Health\u00a0International LLC.\u00a0The remaining authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}